Overcoming Complexity On A Phase 2 Glaucoma Study
Source: Chiltern
A Phase I/II multi-site study needed to enroll more than 100 patients across three distinct cohorts on an exceeding complex protocol:
- Multiple pre-dosing IOP measurements required for eligibility.
- Strict inclusion based on best-corrected visual acuity (BCVA), cup-to-disc ratio, central corneal thickness; exclusion for recent ocular surgery any history of laser or instrumental orbital surgery, and
- Patients subjected to major lifestyle and dietary restrictions during study participation: no exercise, use of contact lenses, caffeine, chocolate, alcohol, tobacco, vitamins nor analgesics.
- Limited use of oral calcium channel blockers and beta blockers.
- wice-daily office visits requiring multiple procedures, overnight IOP assessments and
The Sponsor implemented 7 protocols amendments over 13 months.
access the Case Study!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
This website uses cookies to ensure you get the best experience on our website. Learn more